Notice2026-03362

Requirements for Additional Traceability Records for Certain Foods; Exemption for Cottage Cheese Regulated by the National Conference on Interstate Milk Shipments Grade “A” Pasteurized Milk Ordinance

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
February 20, 2026
Effective
February 20, 2026

Issuing agencies

Health and Human Services DepartmentFood and Drug Administration

Abstract

The Food and Drug Administration (FDA, the Agency, or we) is announcing that we are granting an exemption for certain cottage cheese products from the requirements of the rule titled "Requirements for Additional Traceability Records for Certain Foods" (the Food Traceability Rule). The Agency is taking this action in accordance with the FDA Food Safety Modernization Act and FDA's implementing regulations.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 34 (Friday, February 20, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 34 (Friday, February 20, 2026)]
[Notices]
[Pages 8256-8259]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-03362]



[[Page 8256]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2024-N-1939]


Requirements for Additional Traceability Records for Certain 
Foods; Exemption for Cottage Cheese Regulated by the National 
Conference on Interstate Milk Shipments Grade ``A'' Pasteurized Milk 
Ordinance

AGENCY: Food and Drug Administration, HHS.

ACTION: Notification of exemption.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is 
announcing that we are granting an exemption for certain cottage cheese 
products from the requirements of the rule titled ``Requirements for 
Additional Traceability Records for Certain Foods'' (the Food 
Traceability Rule). The Agency is taking this action in accordance with 
the FDA Food Safety Modernization Act and FDA's implementing 
regulations.

DATES: This exemption is effective on February 20, 2026.

ADDRESSES: For access to the docket to read background documents or 
comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and insert the 
docket number found in brackets in the heading of this document into 
the ``Search'' box and follow the prompts, and/or go to the Dockets 
Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Katie Vierk, Office of Surveillance 
Strategy and Risk Prioritization, Human Foods Program, Food and Drug 
Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-2122, 
<a href="/cdn-cgi/l/email-protection#cf84aebba7aabda6a1aae199a6aabda48fa9abaee1a7a7bce1a8a0b9"><span class="__cf_email__" data-cfemail="a9e2c8ddc1ccdbc0c7cc87ffc0ccdbc2e9cfcdc887c1c1da87cec6df">[email&#160;protected]</span></a>; or Alissa Van Wie, Office of Policy and 
International Engagement, Human Foods Program, Food and Drug 
Administration, 5001 Campus Dr., College Park, MD 20740, 240-654-7524, 
<a href="/cdn-cgi/l/email-protection#a2e3cecbd1d1c38cf4c3ccf5cbc7e2c4c6c38ccacad18cc5cdd4"><span class="__cf_email__" data-cfemail="f5b4999c868694dba3949ba29c90b5939194db9d9d86db929a83">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION:

I. Background

    On November 21, 2022, FDA published in the Federal Register (87 FR 
70910) a final rule titled ``Requirements for Additional Traceability 
Records for Certain Foods'' (the Food Traceability Rule), which 
established additional recordkeeping requirements for persons who 
manufacture, process, pack, or hold foods the Agency has designated for 
inclusion on the Food Traceability List (FTL). In the preamble to the 
final rule, we announced our intention to consider initiating a process 
under the new regulation (codified in subpart S of part 1 of title 21 
of the Code of Federal Regulations (CFR)) to determine whether to 
exempt cottage cheese regulated under the Grade ``A'' Pasteurized Milk 
Ordinance (PMO) from the requirements of the Food Traceability Rule (87 
FR 70910 at 70932).
    On June 17, 2024, FDA published a notice in the Federal Register 
(89 FR 51281) (``2024 Notice'') announcing that the Agency was 
initiating a process in accordance with Sec.  1.1360 (21 CFR 1.1360) et 
seq. to determine whether it would be appropriate to exempt Grade ``A'' 
cottage cheese that appears on the Interstate Milk Shippers (IMS) List 
(``IMS listed Grade ``A'' cottage cheese'') from the Food Traceability 
Rule. FDA received several comments in response to the notice of the 
proposed exemption, as discussed below. In this notice we are 
announcing our determination that granting this exemption is 
appropriate, and we are therefore granting the exemption.
    This action exempts entities that handle IMS listed Grade ``A'' 
cottage cheese from the regulatory requirements of the Food 
Traceability Rule that would otherwise apply to their handling of that 
product.

II. IMS Listed Grade ``A'' Cottage Cheese

    As noted in the 2024 Notice, cottage cheese is currently covered by 
the Food Traceability Rule because it is included on the FTL in the 
commodity ``Cheese (made from pasteurized milk), fresh soft or soft 
unripened.'' However, FDA recognizes that much of the cottage cheese 
produced in the United States is regulated through the National 
Conference on Interstate Milk Shipments (NCIMS). NCIMS is a cooperative 
program among the United States Public Health Service (USPHS), FDA, the 
States, and the dairy industry, with the objective of promoting the 
availability of a high-quality milk supply (Ref. 1 and Ref. 2). FDA and 
NCIMS have together developed a cooperative, Federal-State program (the 
Interstate Milk Shippers Program, or IMS Program) to ensure the 
sanitary quality of milk and milk products shipped interstate. All 50 
States and the District of Columbia participate in the IMS Program.
    The IMS Program is implemented and enforced by the States, with FDA 
providing oversight, including scientific, technical, and inspection 
expertise as set forth in an active 1977 Memorandum of Understanding 
(MOU) between FDA and NCIMS (Ref. 2). As described in the MOU, the IMS 
Program relies on the Pasteurized Milk Ordinance (PMO). The PMO 
incorporates relevant Federal requirements and related technical 
documents for the sanitary standards, requirements, and procedures it 
follows to ensure the safety and wholesomeness of Grade ``A'' milk and 
milk products, including cottage cheese. FDA considers these standards, 
requirements, and procedures to be adequate for the protection of the 
health and safety of the consumer (Ref. 2). The NCIMS recommends 
changes and modifications to the PMO and other related technical 
documents at its biennial conferences (Ref. 3). This ensures that the 
PMO represents the most current science-based knowledge and experience 
concerning the safe production and processing of Grade ``A'' milk 
products and incorporates the latest Federal requirements for food 
safety (Ref. 3).
    The discussion of the PMO in the 2024 Notice was based on the 2019 
Revision of the PMO. On August 9, 2024, FDA announced the availability 
of the 2023 Revision of the PMO (Ref. 4 and Ref. 5). This revision does 
not include any significant changes to the processing requirements for 
cottage cheese. We noted in the 2024 Notice that we did not expect 
future revisions of the PMO to deviate from the 2019 Revision in 
material ways that would affect our conclusion that IMS listed Grade 
``A'' cottage cheese should be exempt from the requirements of subpart 
S, nor did we think past revisions were materially different in ways 
that would affect this conclusion. This continues to be our 
expectation, and after reviewing the 2023 Revision we have concluded 
that it does not deviate from the 2019 Revision in ways that are 
material to our conclusion that IMS listed Grade ``A'' cottage cheese 
should be exempt from the requirements of subpart S.
    Interstate milk and milk product shippers who have been certified 
by Milk Sanitation Rating Officers as having attained certain 
identified sanitation compliance, and enforcement ratings are listed on 
the IMS List. Such certification is based on compliance with the 
requirements of the PMO. The 2024 Notice proposed to exempt IMS listed 
Grade ``A'' cottage cheese from the requirements of the Food 
Traceability Rule because of the specific processing requirements 
specified in the PMO that address the risk factors that resulted in the 
commodity ``Cheese (made from pasteurized milk), fresh soft or soft 
unripened'' being on the FTL

[[Page 8257]]

(and that therefore resulted in cottage cheese being on the FTL), and 
because of the enhanced regulatory oversight of the manufacturing of 
IMS listed Grade ``A'' cottage cheese. As discussed below, this 
document affirms that conclusion.

III. Comments on Notice of Proposed Exemption

    FDA received several comments in response to the 2024 Notice. We 
summarize and respond to relevant portions of comments in this notice. 
To make it easier to identify comments and FDA's responses to the 
comments, the word ``Comment'' will appear in parentheses before the 
description of the comment, and the word ``Response'' will appear in 
parentheses before FDA's response. We have also numbered each comment 
to help distinguish between different comments. The number assigned to 
each comment is for organizational purposes only and does not signify 
the comment's value, importance, or the order in which it was 
submitted.
    (Comment 1) Several comments assert that an exemption for IMS 
listed Grade ``A'' cottage cheese would reduce the regulatory burden 
without compromising food safety. These comments also maintain that 
that the primary risks associated with cottage cheese, specifically 
contamination with Listeria monocytogenes, are adequately mitigated 
through the PMO's requirements for pasteurization, environmental 
controls, and regular inspections. Comments also assert that enhanced 
regulatory oversight through the IMS Program provides ample safeguards 
that render additional traceability records unnecessary for IMS listed 
Grade ``A'' cottage cheese.
    (Response 1) FDA agrees. As discussed in the 2024 Notice, with 
regard to IMS listed Grade ``A'' cottage cheese, we believe an 
exemption is appropriate because of the processing requirements 
specified in the PMO that address the risk factors that ultimately 
resulted in cottage cheese being included on the FTL as part of the 
commodity ``Cheese (made from pasteurized milk), fresh soft or soft 
unripened,'' and because of the enhanced regulatory oversight of the 
manufacturing of IMS listed Grade ``A'' cottage cheese through the IMS 
Program.
    (Comment 2): One comment maintains it will be important to ensure 
that future revisions of the PMO continue to uphold these stringent 
standards and that if any changes in the PMO weaken safety controls, 
the exemption should be reconsidered to ensure ongoing protection of 
public health.
    (Response 2) FDA agrees with this comment. As noted in the 2024 
Notice, this exemption applies to any IMS listed Grade ``A'' cottage 
cheese, including Grade ``A'' cottage cheese regulated under the 2019 
Revision of the PMO or earlier revisions of the PMO (in jurisdictions 
that might not have adopted the 2019 Revision) and any IMS listed Grade 
``A'' cottage cheese regulated under future revisions of the PMO, once 
such revisions are released and adopted. As discussed above, we have 
reviewed the 2023 Revision of the PMO and concluded that it does not 
deviate from the 2019 Revision in ways that are material to our 
conclusion that IMS listed Grade ``A'' cottage cheese should be exempt 
from the requirements of subpart S. Given that the PMO's requirements 
are based on well-established scientific principles and processes, and 
given FDA's own involvement in the PMO and the Grade ``A'' program 
(along with the involvement of other public health governmental 
entities), we do not expect future revisions of the PMO to deviate from 
the 2019 and 2023 Revisions in material ways that would affect this 
conclusion. If we subsequently determine that it is necessary to revise 
or revoke the exemption in order to protect the public health--either 
because of changes to the PMO or for any other reason--we will follow 
the procedures set forth in Sec. Sec.  1.1395 and 1.1400 (21 CFR 1.1395 
and 1.1400).
    (Comment 3) Some comments maintain that given the rise in 
popularity of cottage cheese as a protein source, the exemption could 
lower manufacturing costs and increase production and sales. They 
assert that these cost reductions should be passed on to consumers, and 
the exemption should not come at the risk of public health.
    (Response 3) FDA agrees that any exemption from the requirements of 
the Food Traceability Rule should be based on the risk to public 
health. As noted above, FDA is finalizing this exemption in accordance 
with Sec.  1.1360 et seq. Section 1.1360(a) states, in part, that FDA 
will exempt a food or type of entity from the Food Traceability Rule 
when we determine that application of the requirements that would 
otherwise apply to the food or type of entity is not necessary to 
protect the public health. We are exempting IMS listed Grade ``A'' 
cottage cheese from the requirements of the Food Traceability Rule 
because the processing requirements specified in the PMO address the 
risk factors that resulted in cottage cheese being included on the FTL, 
and because of the enhanced regulatory oversight of the manufacturing 
of IMS listed Grade ``A'' cottage cheese through the IMS Program. The 
popularity of cottage cheese as a protein source and the potential 
impact of the exemption on manufacturers' production costs are not 
relevant to the standard set forth in Sec.  1.1360(a) and therefore 
were not considered in our evaluation to determine whether an exemption 
is appropriate.
    (Comment 4) One comment notes that the inclusion of cottage cheese 
on the FTL was based on a comprehensive risk-ranking model, which 
identified ``Cheese (made from pasteurized milk), fresh soft or soft 
ripened'' as having a significant risk of contamination by Listeria 
monocytogenes, primarily based on the potential for post-pasteurization 
contamination. The comment expresses concern that the proposed 
exemption overlooks that environmental risks associated with such 
contamination are still substantial, and maintains that ensuring 
traceability is essential for promptly identifying and mitigating 
public health risks. The comment also contends that the effectiveness 
of the IMS Program heavily depends on consistent implementation and 
enforcement across all states.
    (Response 4) FDA disagrees with this comment insofar as it argues 
that exempting IMS listed Grade ``A'' cottage cheese would have an 
adverse effect on the public health. As described in detail in the 2024 
Notice, manufacturers of IMS listed Grade ``A'' cottage cheese must 
comply with PMO requirements intended to control pathogens during 
pasteurization and to prevent contamination during post-pasteurization 
processing (Ref. 5). Additionally, there are requirements in the PMO 
pertaining to information that must be documented in records, and 
provisions that dictate inspectional and sampling frequencies (Ref. 5). 
We have concluded that these measures provide protections adequate to 
address the risk factors that resulted in the commodity ``Cheese (made 
from pasteurized milk), fresh soft or soft unripened'' being on the 
FTL.
    More specifically, FDA recognizes that the cottage cheese 
processing steps that occur after milk pasteurization but prior to 
packaging can present a risk for contamination of in-process food with 
environmental pathogens, such as L. monocytogenes, if sanitary 
conditions are not maintained. However, we believe the post-
pasteurization processing requirements included in the PMO adequately 
address these risk factors. The PMO contains specific

[[Page 8258]]

requirements for the control of critical factors including, but not 
limited to, pH, filling temperature, and the use of microbial 
inhibitors and preservatives to address post-pasteurization 
contamination (Ref. 3).
    Finally, we note that this exemption from the Food Traceability 
Rule's enhanced recordkeeping requirements does not alter the 
applicability of other laws and regulations related to the 
manufacturing, processing, packing, or holding of food. Furthermore, in 
accordance with Sec.  1.1360(b), if a person to whom this exemption 
applies (including a person who manufactures, processes, packs, or 
holds IMS listed Grade ``A'' cottage cheese) is required to register 
with FDA under section 415 of the Federal Food, Drug, and Cosmetic Act 
(FD&C Act) (per the requirements of 21 CFR part 1, subpart H) with 
respect to the manufacturing, processing, packing, or holding of the 
applicable food, such person must maintain records identifying the 
immediate previous source of such food and the immediate subsequent 
recipient of such food in accordance with Sec. Sec.  1.337 and 1.345 
(21 CFR 1.337 and 1.345). Such records must be maintained for 2 years.
    (Comment 5) One comment questions the need to exempt cottage cheese 
from the Food Traceability Rule while other dairy products are not 
exempted. The comment maintains that despite the controls put in place 
by the PMO, cottage cheese still falls into the category of higher-risk 
dairy products. This comment also asserts that despite the enhanced 
regulatory oversight provided by the IMS Program and the PMO, cottage 
cheese manufactured in the U.S. is already below international quality 
standards, and it is unclear how lowering the safety standards could be 
beneficial for end consumers.
    (Response 5) There are many dairy products that are not included on 
the FTL and therefore are not subject to the Food Traceability Rule. Of 
the dairy products that are on the FTL, cottage cheese is the only one 
that is addressed by the PMO. As noted above, FDA has concluded that 
the requirements and other provisions associated with IMS listed Grade 
``A'' cottage cheese are adequate to address the risk factors that 
resulted in the commodity ``Cheese (made from pasteurized milk), fresh 
soft or soft unripened'' being on the FTL.
    The comment does not indicate which international quality standards 
they are referring to; regardless, food quality measures do not 
necessarily ensure food safety. In addition, we note that exempting IMS 
listed Grade ``A'' cottage cheese from the Food Traceability Rule does 
not lower safety standards; rather, it reflects the determination that 
existing regulatory requirements applicable to these products make it 
unnecessary to apply the recordkeeping requirements of the Food 
Traceability Rule.
    (Comment 6) One comment maintains that in modern society, consumers 
value transparency and accountability in the food supply chain. The 
comment asserts that the proposal to exempt certain products from a 
rule previously in place could erode consumer confidence, particularly 
if there are subsequent food safety incidents involving cottage cheese 
or similar products. The comment argues that ensuring full traceability 
aligns with FDA's mission to protect public health and reinforces the 
Agency's credibility.
    (Response 6) In the preamble to the Food Traceability Rule, FDA 
announced that we were considering initiating a process to determine 
whether to exempt cottage cheese regulated under the PMO from the 
rule's requirements (87 FR 70910 at 70932). We have taken steps to 
finalize this exemption prior to the rule's compliance date. We 
therefore do not agree with the comment's implication that this 
exemption will be inconsistent with consumers' expectations.
    More generally, while we acknowledge the goals expressed in the 
comment, FDA's authority to promulgate the Food Traceability Rule stems 
from section 204(d) of the FDA Food Safety Modernization Act (FSMA), 
under which the rule's requirements must be limited to foods Sec. Sec.  
the Agency designates for inclusion on the Food Traceability List. The 
rule's procedures in 21 CFR 1.1360 et seq. for granting modified 
requirements and exemptions stem from section 204(d)(6)(E) of FSMA. In 
keeping with both of those provisions, FDA may exempt a food or type of 
entity from the rule's requirements when we determine that application 
of the requirements that would otherwise apply to the food or type of 
entity is not necessary to protect the public health. As stated above, 
we believe an exemption for IMS listed Grade ``A'' cottage cheese is 
appropriate because of the processing requirements specified in the PMO 
that address the risk factors that resulted in cottage cheese being 
included on the FTL, and because of the enhanced regulatory oversight 
of the manufacturing of IMS listed Grade ``A'' cottage cheese through 
the IMS Program. If we subsequently determine that it is necessary to 
revise or revoke the exemption for these products in order to protect 
the public health, we will follow the procedures set forth in 
Sec. Sec.  1.1395 and 1.1400.
    (Comment 7) One comment asserts that while cottage cheese is 
currently strictly monitored under the NCIMS based on the PMO 
standards, there have not been any significant changes to the current 
PMO regulations that would prompt the potential exclusion of cottage 
cheese from the Food Traceability Rule.
    (Response 7) This exemption is not based on changes to the PMO 
requirements. As discussed in Response 6, FDA's announcement that we 
were considering initiating the process for this exemption was 
simultaneous with our publication of the Food Traceability Rule. 
Moreover, as discussed in Response 2, this exemption applies to IMS 
listed Grade ``A'' cottage cheese regulated under earlier revisions of 
the PMO (in jurisdictions that might not have adopted the 2019 Revision 
or the 2023 Revision), because we do not think that past revisions were 
materially different in ways that would affect our conclusion that this 
exemption is appropriate.

IV. Conclusion

    As discussed above and as set forth in the 2024 Notice, we proposed 
exempting IMS listed Grade ``A'' cottage cheese from the requirements 
of the Food Traceability Rule because we tentatively concluded that 
application of the Food Traceability Rule to IMS listed Grade ``A'' 
cottage cheese is not necessary to protect the public health in light 
of how such cottage cheese is regulated. Based on the comments received 
on the 2024 Notice, and as discussed above, we conclude an exemption 
for IMS listed Grade ``A'' cottage cheese is appropriate because of the 
processing requirements specified in the PMO that address the risk 
factors that resulted in cottage cheese being included on the FTL, and 
because of the enhanced regulatory oversight of the manufacturing of 
IMS listed Grade ``A'' cottage cheese through the IMS Program.
    Having considered all timely submitted comments, and in accordance 
with 21 CFR 1.1385(b), we are publishing this document to state that we 
are granting an exemption from the Food Traceability Rule for IMS 
listed Grade ``A'' cottage cheese, for the reasons stated above.
    We note that, in accordance with Sec.  1.1360(b), if a person to 
whom this exemption applies (including a person who manufactures, 
processes, packs, or holds IMS listed Grade ``A'' cottage cheese) is 
required to register with FDA under section 415 of the FD&C Act (per 
the requirements of 21 CFR part 1, subpart H) with respect to the

[[Page 8259]]

manufacturing, processing, packing, or holding of the applicable food, 
such person must maintain records identifying the immediate previous 
source of such food and the immediate subsequent recipient of such food 
in accordance with Sec. Sec.  1.337 and 1.345. Such records must be 
maintained for 2 years.
    In accordance with 21 CFR 1.1390, this exemption is effective as of 
the date this document publishes in the Federal Register.

V. References

    The following references are on display at the Dockets Management 
Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 
1061, Rockville, MD 20852, 240-402-7500, and are available for viewing 
by interested persons between 9 a.m. and 4 p.m., Monday through Friday; 
they are also available electronically at <a href="http://www.regulations.gov">http://www.regulations.gov</a>. 
Although FDA verified the website addresses in this document, please 
note that websites are subject to change over time.

1. FDA and NCIMS, ``Procedures Governing the Cooperative State-
Public Health Service/Food and Drug Administration Program of the 
National Conference on Interstate Milk Shipment (2019 Revision)'', 
2019. Available at <a href="https://www.fda.gov/media/138115/download?attachment">https://www.fda.gov/media/138115/download?attachment</a>. Accessed April 17, 2025.
2. FDA and NCIMS, ``Memorandum of Understanding Between the National 
Conference on Interstate Milk Shipments and the Food and Drug 
Administration'', 1977. Available at: <a href="https://www.fda.gov/about-fda/mou-225-78-1000">https://www.fda.gov/about-fda/mou-225-78-1000</a>. Accessed March 26, 2025.
3. FDA, ``Grade ``A'' Pasteurized Milk Ordinance (2019 Revision),'' 
2019. Available at: <a href="https://www.fda.gov/media/140394/download?attachment">https://www.fda.gov/media/140394/download?attachment</a>. Accessed April 17, 2025.
4. FDA Memorandum, ``2023 Revision of the Grade ``A'' Pasteurized 
Milk Ordinance (PMO),'' M-I-24-02, August 9, 2024. Available at: 
<a href="https://gams.fda.gov/active/M-I-24-02-PMO-2023-Revision.pdf">https://gams.fda.gov/active/M-I-24-02-PMO-2023-Revision.pdf</a>. 
Accessed May 1, 2025.
5. FDA, ``Grade ``A'' Pasteurized Milk Ordinance (2023 Revision),'' 
2023. Available at: <a href="https://www.fda.gov/media/180975/download?attachment">https://www.fda.gov/media/180975/download?attachment</a>. Accessed April 17, 2025.

Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2026-03362 Filed 2-19-26; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on February 20, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.